Care management for Type 2 diabetes in the United States

A systematic review and meta-analysis

Jason S. Egginton, Jennifer L. Ridgeway, Nilay D Shah, Saranya Balasubramaniam, Joann R. Emmanuel, Larry J. Prokop, Victor Manuel Montori, Mohammad H Murad

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Background: This systematic review and meta-analysis aims at assessing the composition and performance of care management models evaluated in the last decade and their impact on patient important outcomes. Methods. A comprehensive literature search of electronic bibliographic databases was performed to identify care management trials in type 2 diabetes. Random effects meta-analysis was used when feasible to pool outcome measures. Results: Fifty-two studies were eligible. Most commonly reported were surrogate outcomes (such as HbA1c and LDL), followed by process measures (clinic visit or testing frequency). Less frequently reported were quality of life, patient satisfaction, self-care, and healthcare utilization. Most care management modalities were carved out from primary care. Meta-analysis demonstrated a statistically significant but trivial reduction of HbA1c (weighted difference in means -0.21%, 95% confidence interval -0.40 to -0.03, p <.03) and LDL-cholesterol (weighted difference in means -3.38 mg/dL, 95% confidence interval -6.27 to -0.49, p <.02). Conclusions: Most care management programs for patients with type 2 diabetes are 'carved-out', accomplish limited effects on metabolic outcomes, and have unknown effects on patient important outcomes. Comparative effectiveness research of different models of care management is needed to inform the design of medical homes for patients with chronic conditions.

Original languageEnglish (US)
Article number72
JournalBMC Health Services Research
Volume12
Issue number1
DOIs
StatePublished - 2012

Fingerprint

Type 2 Diabetes Mellitus
Meta-Analysis
Comparative Effectiveness Research
Patient Care Management
Bibliographic Databases
Confidence Intervals
Patient-Centered Care
Process Assessment (Health Care)
Ambulatory Care
Self Care
Patient Satisfaction
LDL Cholesterol
Primary Health Care
Quality of Life
Outcome Assessment (Health Care)
Delivery of Health Care
oxidized low density lipoprotein

Keywords

  • Chronic Care: disease management/care management
  • Endocrinology: diabetes, Evidence-based medicine/critical review of evidence

ASJC Scopus subject areas

  • Health Policy

Cite this

Care management for Type 2 diabetes in the United States : A systematic review and meta-analysis. / Egginton, Jason S.; Ridgeway, Jennifer L.; Shah, Nilay D; Balasubramaniam, Saranya; Emmanuel, Joann R.; Prokop, Larry J.; Montori, Victor Manuel; Murad, Mohammad H.

In: BMC Health Services Research, Vol. 12, No. 1, 72, 2012.

Research output: Contribution to journalArticle

Egginton, Jason S. ; Ridgeway, Jennifer L. ; Shah, Nilay D ; Balasubramaniam, Saranya ; Emmanuel, Joann R. ; Prokop, Larry J. ; Montori, Victor Manuel ; Murad, Mohammad H. / Care management for Type 2 diabetes in the United States : A systematic review and meta-analysis. In: BMC Health Services Research. 2012 ; Vol. 12, No. 1.
@article{adde1ccfbd8045248c94e4d829401893,
title = "Care management for Type 2 diabetes in the United States: A systematic review and meta-analysis",
abstract = "Background: This systematic review and meta-analysis aims at assessing the composition and performance of care management models evaluated in the last decade and their impact on patient important outcomes. Methods. A comprehensive literature search of electronic bibliographic databases was performed to identify care management trials in type 2 diabetes. Random effects meta-analysis was used when feasible to pool outcome measures. Results: Fifty-two studies were eligible. Most commonly reported were surrogate outcomes (such as HbA1c and LDL), followed by process measures (clinic visit or testing frequency). Less frequently reported were quality of life, patient satisfaction, self-care, and healthcare utilization. Most care management modalities were carved out from primary care. Meta-analysis demonstrated a statistically significant but trivial reduction of HbA1c (weighted difference in means -0.21{\%}, 95{\%} confidence interval -0.40 to -0.03, p <.03) and LDL-cholesterol (weighted difference in means -3.38 mg/dL, 95{\%} confidence interval -6.27 to -0.49, p <.02). Conclusions: Most care management programs for patients with type 2 diabetes are 'carved-out', accomplish limited effects on metabolic outcomes, and have unknown effects on patient important outcomes. Comparative effectiveness research of different models of care management is needed to inform the design of medical homes for patients with chronic conditions.",
keywords = "Chronic Care: disease management/care management, Endocrinology: diabetes, Evidence-based medicine/critical review of evidence",
author = "Egginton, {Jason S.} and Ridgeway, {Jennifer L.} and Shah, {Nilay D} and Saranya Balasubramaniam and Emmanuel, {Joann R.} and Prokop, {Larry J.} and Montori, {Victor Manuel} and Murad, {Mohammad H}",
year = "2012",
doi = "10.1186/1472-6963-12-72",
language = "English (US)",
volume = "12",
journal = "BMC Health Services Research",
issn = "1472-6963",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Care management for Type 2 diabetes in the United States

T2 - A systematic review and meta-analysis

AU - Egginton, Jason S.

AU - Ridgeway, Jennifer L.

AU - Shah, Nilay D

AU - Balasubramaniam, Saranya

AU - Emmanuel, Joann R.

AU - Prokop, Larry J.

AU - Montori, Victor Manuel

AU - Murad, Mohammad H

PY - 2012

Y1 - 2012

N2 - Background: This systematic review and meta-analysis aims at assessing the composition and performance of care management models evaluated in the last decade and their impact on patient important outcomes. Methods. A comprehensive literature search of electronic bibliographic databases was performed to identify care management trials in type 2 diabetes. Random effects meta-analysis was used when feasible to pool outcome measures. Results: Fifty-two studies were eligible. Most commonly reported were surrogate outcomes (such as HbA1c and LDL), followed by process measures (clinic visit or testing frequency). Less frequently reported were quality of life, patient satisfaction, self-care, and healthcare utilization. Most care management modalities were carved out from primary care. Meta-analysis demonstrated a statistically significant but trivial reduction of HbA1c (weighted difference in means -0.21%, 95% confidence interval -0.40 to -0.03, p <.03) and LDL-cholesterol (weighted difference in means -3.38 mg/dL, 95% confidence interval -6.27 to -0.49, p <.02). Conclusions: Most care management programs for patients with type 2 diabetes are 'carved-out', accomplish limited effects on metabolic outcomes, and have unknown effects on patient important outcomes. Comparative effectiveness research of different models of care management is needed to inform the design of medical homes for patients with chronic conditions.

AB - Background: This systematic review and meta-analysis aims at assessing the composition and performance of care management models evaluated in the last decade and their impact on patient important outcomes. Methods. A comprehensive literature search of electronic bibliographic databases was performed to identify care management trials in type 2 diabetes. Random effects meta-analysis was used when feasible to pool outcome measures. Results: Fifty-two studies were eligible. Most commonly reported were surrogate outcomes (such as HbA1c and LDL), followed by process measures (clinic visit or testing frequency). Less frequently reported were quality of life, patient satisfaction, self-care, and healthcare utilization. Most care management modalities were carved out from primary care. Meta-analysis demonstrated a statistically significant but trivial reduction of HbA1c (weighted difference in means -0.21%, 95% confidence interval -0.40 to -0.03, p <.03) and LDL-cholesterol (weighted difference in means -3.38 mg/dL, 95% confidence interval -6.27 to -0.49, p <.02). Conclusions: Most care management programs for patients with type 2 diabetes are 'carved-out', accomplish limited effects on metabolic outcomes, and have unknown effects on patient important outcomes. Comparative effectiveness research of different models of care management is needed to inform the design of medical homes for patients with chronic conditions.

KW - Chronic Care: disease management/care management

KW - Endocrinology: diabetes, Evidence-based medicine/critical review of evidence

UR - http://www.scopus.com/inward/record.url?scp=84858733804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858733804&partnerID=8YFLogxK

U2 - 10.1186/1472-6963-12-72

DO - 10.1186/1472-6963-12-72

M3 - Article

VL - 12

JO - BMC Health Services Research

JF - BMC Health Services Research

SN - 1472-6963

IS - 1

M1 - 72

ER -